Projected Earnings Date: 2025-10-29    (Delayed quote data   2025-09-15)
Last
 114.29
Change
 ⇓ -0.28   (-0.24%)
Volume
  659,984
Open
 114.84
High
 117.24
Low
 113.84
8EMA (Daily)
 112.08
40EMA (Daily)
 115.70
50EMA (Daily)
 115.89
STO (Daily)
 54.413
MACD Hist (Daily)
 1.062
8EMA (Weekly)
 114.919
40EMA (Weekly)
 107.73
50EMA (Weekly)
 106.19
STO (Weekly)
 31.422
MACD Hist (Weekly)
 -3.279
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com